271 related articles for article (PubMed ID: 804952)
1. Double-blind comparison of tolamolol, propranolol, practolol, and placebo in the treatment of angina pectoris.
Jackson G; Atkinson L; Oram S
Br Med J; 1975 Mar; 1(5960):708-12. PubMed ID: 804952
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the immediate effects of five beta-adrenoreceptor-blocking drugs with different ancillary properties in angina pectoris.
Thadani U; Davidson C; Singleton W; Taylor SH
N Engl J Med; 1979 Apr; 300(14):750-5. PubMed ID: 581782
[TBL] [Abstract][Full Text] [Related]
3. Comparison of five beta-adrenoreceptor antagonists with different ancillary properties during sustained twice daily therapy in angina pectoris.
Thadani U; Davidson C; Singleton W; Taylor SH
Am J Med; 1980 Feb; 68(2):243-50. PubMed ID: 6101934
[TBL] [Abstract][Full Text] [Related]
4. Effect of tolamolol and propranolol on exercise heart rate and angina.
Aronow WS; Spivacek N; Laverty W; Warren M
Clin Pharmacol Ther; 1975 Apr; 17(4):379-84. PubMed ID: 1173059
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of practolol, a new cardioselective beta-blocking agent in angina pectoris.
Sandler G; Clayton GA
Br Med J; 1970 May; 2(5706):399-402. PubMed ID: 4392983
[TBL] [Abstract][Full Text] [Related]
6. Comparison of celiprolol and propranolol in stable angina pectoris. Celiprolol International Angina Study Group.
Frishman WH; Heiman M; Soberman J; Greenberg S; Eff J
Am J Cardiol; 1991 Apr; 67(8):665-70. PubMed ID: 1672481
[TBL] [Abstract][Full Text] [Related]
7. Comparison of atenolol with propranolol in the treatment of angina pectoris with special reference to once daily administration of atenolol.
Jackson G; Harry JD; Robinson C; Kitson D; Jewitt DE
Br Heart J; 1978 Sep; 40(9):998-1004. PubMed ID: 101223
[TBL] [Abstract][Full Text] [Related]
8. Isoprenaline- and exercise- induced tachycardia in the assessment of beta-adrenoceptor blocking drugs; a comparison between tolamolol, practolol and propranolol.
Adam KR; Pullman LG; Scholfield PC
Br J Pharmacol; 1973 Nov; 49(3):560-3. PubMed ID: 4149697
[TBL] [Abstract][Full Text] [Related]
9. Treatment of spontaneous angina pectoris with beta blocking agents. A clinical, electrocardiographic, and haemodynamic appraisal.
Guazzi M; Fiorentini C; Polese A; Magrini F; Olivari MT
Br Heart J; 1975 Dec; 37(12):1235-45. PubMed ID: 773391
[TBL] [Abstract][Full Text] [Related]
10. Double-blind comparison of verapamil and practolol in the treatment of angina pectoris.
Fagher B; Persson S; Svensson SE
Postgrad Med J; 1977 Feb; 53(616):61-5. PubMed ID: 406602
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of long-acting and conventional propranolol on stress-induced angina pectoris and on frequency of ventricular premature beats.
Hansteen V; Endresen K; Hellemann H; Eriksen II; Brorssen O; Ekeli T; Day M; Baber NS
Br J Clin Pharmacol; 1984 May; 17(5):579-84. PubMed ID: 6203546
[TBL] [Abstract][Full Text] [Related]
12. Clinical trial of a new beta-receptor blocking agent, tolamolol, in angina pectoris.
Nordenfelt I; Olsson L; Persson S
Eur J Clin Pharmacol; 1974; 7(3):157-62. PubMed ID: 4152812
[No Abstract] [Full Text] [Related]
13. Effect of new beta-adrenergic blocking agent, Atenolol (Tenormin), on pain frequency, trinitrin consumption, and exercise ability.
Roy P; Day L; Sowton E
Br Med J; 1975 Jul; 3(5977):195-7. PubMed ID: 238716
[TBL] [Abstract][Full Text] [Related]
14. Clinical investigations into the effects of practolol in angina pectoris.
Chlebus H; Jarecki M; Waclawek J; Kadzielawa R
Cor Vasa; 1977; 19(1):1-11. PubMed ID: 326482
[TBL] [Abstract][Full Text] [Related]
15. Antianginal efficacy and improved exercise performance with timolol. Twice-daily beta blockade in ischemic heart disease.
Harris FJ; Low RI; Paumer L; Amsterdam EA; Mason DT
Am J Cardiol; 1983 Jan; 51(1):13-8. PubMed ID: 6129794
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of three beta 1-adrenoreceptor blocking drugs with different degree of intrinsic stimulating activity (metoprolol, practolol and H 87/07) in patients with angina pectoris.
Keyriläinen O; Uusitalo A
Ann Clin Res; 1978 Aug; 10(4):185-90. PubMed ID: 30388
[TBL] [Abstract][Full Text] [Related]
17. Comparison of oral propranolol and verapamil for combined systemic hypertension and angina pectoris. A placebo-controlled double-blind randomized crossover trial.
Frishman WH; Klein NA; Klein P; Strom JA; Tawil R; Strair R; Wong B; Roth S; LeJemtel TH; Pollack S; Sonnenblick EH
Am J Cardiol; 1982 Nov; 50(5):1164-72. PubMed ID: 6127946
[TBL] [Abstract][Full Text] [Related]
18. [Double-blind, placebo-controlled trial of propranolol vs celiprolol in stable effort angina: antianginal efficacy and side effects ].
Klein W; Fluch N; Brandt D
Wien Klin Wochenschr; 1982 May; 94(10):258-61. PubMed ID: 6126961
[TBL] [Abstract][Full Text] [Related]
19. Assessment of metoprolol, a cardioselective beta-blocking agent, during chronic therapy in patients with angina pectoris.
Borer JS; Comerford MB; Sowton E
J Int Med Res; 1976; 4(1):15-22. PubMed ID: 799974
[TBL] [Abstract][Full Text] [Related]
20. Double-blind titrated-dose comparison of metoprolol and propranolol in the treatment of angina pectoris.
Frick MH; Luurila O
Ann Clin Res; 1976 Dec; 8(6):385-92. PubMed ID: 795362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
